Ignite Creation Date:
2024-05-19 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06410976
Status:
RECRUITING
Last Update Posted:
2024-06-25
First Post:
2024-05-08
Brief Title:
Prospective Clinical Assessment Study in Children with Hypochondroplasia
Sponsor:
QED Therapeutics Inc
Organization:
QED Therapeutics Inc
Study Overview
Official Title:
Prospective Clinical Assessment Study in Children with Hypochondroplasia ACCEL
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HCH
Brief Summary:
This is a long-term multicenter non-interventional study of children ages 25 to 17 years with hypochondroplasia HCH
Detailed Description:
The objective is to evaluate growth HCH-related medical complications health-related quality of life functional abilities and cognitive functions of study participants Data collected will contribute to the characterization of the natural history of children with HCH No study medication will be administered
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None